Table 1 Comparison of the expression of surface markers of UCB-MSCs from passage two to eight.
CD29 | CD44 | CD73 | CD90 | CD105 | CD146 | CD166 | |
|---|---|---|---|---|---|---|---|
P2 | 98.4 ± 2.03 | 100 ± 0.07 | 98.8 ± 1.44 | 72.7 ± 27.8 | 93.4 ± 2.37 | 41.1 ± 37.8 | 98.7 ± 0.75 |
P3 | 99.3 ± 0.62 | 99.9 ± 0.34 | 99.3 ± 0.66 | 81.5 ± 30.1 | 92 ± 9.36 | 69.5 ± 21.3 | 97.5 ± 3.35 |
P4 | 97.3 ± 5.23 | 99.9 ± 0.19 | 99.2 ± 1.07 | 77 ± 24.3 | 91.9 ± 10 | 50.5 ± 29.5 | 97.4 ± 1.8 |
P5 | 98.6 ± 2.04 | 99.9 ± 0.09 | 97.9 ± 3.14 | 60.2 ± 32.6 | 92.1 ± 9.76 | 51.3 ± 26.6 | 93.9 ± 5.54 |
P6 | 98.4 ± 1.70 | 99.8 ± 0.35 | 99.2 ± 1.19 | 81.4 ± 36.1 | 87.8 ± 11.0 | 24.1 ± 23.3 | 98.5 ± 0.94 |
P7 | 96.4 ± 3.44 | 99.5 ± 0.62 | 96.6 ± 3.53 | 93.4 ± 8.69 | 91.5 ± 4.24 | 25.2 ± 22.8 | 97.4 ± 2.28 |
P8 | 98.0 ± 0.93 | 100 ± 0.05 | 99.4 ± 0.85 | 79.5 ± 39.1 | 80.5 ± 25.2 | 26.5 ± 33.5 | 98.2 ± 0.50 |
